Kavitha Yaddanapudi

Department of Surgery,
Immuno-Oncology Program,
Brown Cancer Center,
Department of Microbiology and Immunology,
School of Medicine,
Immuno-Oncology Program, Brown Cancer Center

University of Louisville

BIOGRAPHY

Kavitha Yaddanapudi has not added Biography.

If you are Kavitha Yaddanapudi and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Cancer vaccines: Looking to the future.

Oncoimmunology Mar, 2013 | Pubmed ID: 23802081

Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible?

PloS one , 2012 | Pubmed ID: 22860107

Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.

The Journal of biological chemistry Nov, 2012 | Pubmed ID: 22988252

Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.

Journal of immunology (Baltimore, Md. : 1950) Mar, 2013 | Pubmed ID: 23390297

MIF family members cooperatively inhibit p53 expression and activity.

PloS one , 2014 | Pubmed ID: 24932684

Multi-peptide immunotherapeutic vaccine for renal cell carcinoma: getting the troops all worked up.

Translational andrology and urology Dec, 2012 | Pubmed ID: 25221745

Stromal-dependent tumor promotion by MIF family members.

Cellular signalling Dec, 2014 | Pubmed ID: 25277536

The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.

Oncotarget Mar, 2015 | Pubmed ID: 25609198

MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.

Cancer immunology research Feb, 2016 | Pubmed ID: 26603621

MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes.

Genomics data Mar, 2016 | Pubmed ID: 26981417

Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.

Oncotarget Dec, 2016 | Pubmed ID: 27566591

Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin.

F1000Research , 2016 | Pubmed ID: 28299174

The soy-derived peptide Lunasin inhibits invasive potential of melanoma initiating cells.

Oncotarget Apr, 2017 | Pubmed ID: 28424421

Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy.

Journal of leukocyte biology 09, 2017 | Pubmed ID: 28546500

Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.

Cancer biology & therapy 03, 2018 | Pubmed ID: 29252087

Vaccination with induced pluripotent stem cells confers protection against cancer.

Stem cell investigation , 2018 | Pubmed ID: 30148156

Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention.

Oncoimmunology , 2019 | Pubmed ID: 30723593

Simultaneous Quantification of Nucleosides and Nucleotides from Biological Samples.

Journal of the American Society for Mass Spectrometry Jun, 2019 | Pubmed ID: 30847833

Detection of Inflammation-Related Melanoma Small Extracellular Vesicle (sEV) mRNA Content Using Primary Melanocyte sEVs as a Reference.

International journal of molecular sciences Mar, 2019 | Pubmed ID: 30870978

Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the Envelope.

Frontiers in immunology , 2020 | Pubmed ID: 32765528

Cancer Vaccines: Promising Therapeutics or an Unattainable Dream.

Vaccines Jun, 2021 | Pubmed ID: 34207062

INSTITUTIONS

University of Louisville

JOVE ARTICLES

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells

Shuhan Meng^1,2,

Aaron G. Whitt^1,2,3,

Allison Tu²,

John W. Eaton^1,2,3,

Chi Li^1,2,3,

Kavitha Yaddanapudi^4,5,6

¹Department of Pharmacology and Toxicology, University of Louisville,

²Experimental Therapeutics Program, Brown Cancer Center, University of Louisville,

³Department of Medicine, University of Louisville,

⁴Department of Surgery, University of Louisville,

⁵Immuno-Oncology Program, Brown Cancer Center, University of Louisville,

⁶Department of Microbiology and Immunology, University of Louisville

Cancer Research

Assembly and Operation of an Acoustofluidic Device for Enhanced Delivery of Molecular Compounds to Cells

Connor S. Centner¹,

Emily M. Murphy¹,

Bryce F. Stamp²,

Mariah C. Priddy¹,

John T. Moore¹,

Paula J. Bates²,

Michael A. Menze³,

Kavitha Yaddanapudi²,

Jonathan A. Kopechek¹

¹Department of Bioengineering, University of Louisville,

²School of Medicine, University of Louisville,

³Department of Biology, University of Louisville

Bioengineering

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog

Kavitha Yaddanapudi

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Surgery,Immuno-Oncology Program,Brown Cancer Center,Department of Microbiology and Immunology,School of Medicine,Immuno-Oncology Program, Brown Cancer Center

University of Louisville

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells

Assembly and Operation of an Acoustofluidic Device for Enhanced Delivery of Molecular Compounds to Cells

Department of Surgery,
Immuno-Oncology Program,
Brown Cancer Center,
Department of Microbiology and Immunology,
School of Medicine,
Immuno-Oncology Program, Brown Cancer Center